about
The persistency of high levels of pSTAT3 expression in circulating CD4+ T cells from CIS patients favors the early conversion to clinically defined multiple sclerosisPoly-autoimmunity in patients with myasthenia gravis: A single-center experience.Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4.Distinctive clinical and neuroimaging characteristics of longitudinally extensive transverse myelitis associated with aquaporin-4 autoantibodies.Syndrome of inappropriate antidiuresis may herald or accompany neuromyelitis opticaDevelopment of an Aquaporin-4 Orthogonal Array of Particle-Based ELISA for Neuromyelitis Optica Autoantibodies Detection.Copper deficiency myelopathy: A report of two cases.Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.Neural antigen-specific autoimmune disorders.Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis.Myasthenia gravis with presynaptic neurophysiological signs: Two case reports and literature review.Overcoming challenges in the diagnosis and treatment of myasthenia gravis.Pattern of ocular involvement in myasthenia gravis with MuSK antibodies.Acute necrotizing encephalopathy during novel influenza A (H1N1) virus infection.Post-Encephalitic Parkinsonism and Sleep Disorder Responsive to Immunological Treatment: A Case Report.T-bet and pSTAT-1 expression in PBMC from coeliac disease patients: new markers of disease activity.Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma.Epstein-Barr virus antibodies in serum and cerebrospinal fluid from multiple sclerosis, chronic inflammatory demyelinating polyradiculoneuropathy and amyotrophic lateral sclerosis.Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia.Paroxysmal ataxia and dysarthria in multiple sclerosis.Febrile infection-related epilepsy syndrome (FIRES) with super-refractory status epilepticus revealing autoimmune encephalitis due to GABAAR antibodies.Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients.Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens.A Case of Hemiabdominal Myoclonus.Increased CD4+CD25+Foxp3+ T cells in peripheral blood of celiac disease patients: correlation with dietary treatment.Sleep disorder associated with antibodies to IgLON5: parasomnia or agrypnia?Neurological picture. Pseudoperipheral tongue weakness.Treatment-Resistant Depression and Aquaporin-4 Autoantibodies: Is There a Link?Multiple sclerosis attacks triggered by hyperprolactinemia.pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity.The detection of neural autoantibodies in patients with antiepileptic-drug-resistant epilepsy predicts response to immunotherapy.Efficacy of oral corticosteroids therapy in anti-glutamic acid decarboxylase antibodies cerebellar ataxia.SIADH in a patient with sensory ataxic neuropathy with anti-disialosyl antibodies (CANOMAD).Glioblastoma in multiple sclerosis: a case report.Movement disorders in multiple sclerosis: Causal or coincidental association?Teaching NeuroImages: Gasperini syndrome.Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis.Remission of myasthenia gravis with MuSK antibodies during ruxolitinib treatment.Focal Hyperhidrosis in Tumefactive Multiple SclerosisGlucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients
P50
Q28297721-E8735A23-13AD-4B01-9C58-BB2AA5FE2E36Q33421946-D01722EE-9F64-44A7-A725-BB4B17055EE8Q34464610-D20841AD-CD36-4B08-B4C0-0650B7AF5987Q34781691-D5F6F8A4-F5D8-4C00-8756-A38148C187F4Q35416774-306DFCF2-97E5-40C5-BE92-631168ED61CBQ35850484-0AE00483-F4DF-4263-9AAA-C5E1C26EB80AQ36181062-E7EB8543-B204-41AB-97FD-9EA172B4BB45Q37227096-032E6679-6BC6-4B77-9C89-28A29FB45858Q38020960-59B80F58-D1E7-4C1B-A037-A519357A4BDDQ38259495-AF5A2E75-107A-40B1-90CF-B131BDF041EFQ38509656-2C2589A7-EAF6-4000-88F2-6664A0A2C296Q38671442-401765BC-C120-421E-BDAD-A1144AFA485CQ40164717-3A72753D-4483-4149-AF8E-D9562589F50AQ40355459-D197405E-4A65-4CD1-8221-0F5364C9959FQ40495995-57594BBE-025F-479D-AD58-AD70EF4990E3Q43967781-A8619CED-8838-4002-BBF3-441BEFD585C3Q44025134-638B8DDA-5F05-4EA3-91AA-740B4EB60601Q45375678-530B3445-1E02-4694-99F5-628194988A51Q46018967-3B6620D0-5185-4D68-A81E-6F530BC09F64Q46427580-E841E207-2D76-4986-A5CC-BD455AF40E73Q47224677-1CB69149-52DE-47E9-962A-67B9A387CE2CQ47259734-9017DA9E-CEE6-4C5D-A85C-96EF658B8029Q47654624-05523BA9-5CDD-457A-B984-D5E628FDE348Q47802075-54B22145-C768-4CD7-88F8-7EA988EBC1E0Q48013153-1B3DA541-020C-4481-8757-035B8BA7C26EQ48035573-4B112513-9C2E-4BD8-8EE7-27A800CC5441Q48155859-84C0C564-6898-4C8D-AC23-8B2A39A5C32EQ48166239-85C06EE2-E8BC-4BC4-9511-1BFD90F931C3Q48391421-2EF2499B-D88B-4619-89C4-3C60EFE38128Q48463355-FDC23AA8-E123-4F7B-AB07-EC6211F3E158Q48610807-92D0F8DA-819B-420E-9FAF-9E67E8BA70DDQ48709001-790E2B58-4A44-40ED-BE71-E43C5D27A638Q48720063-6576ACFB-7531-453F-A99E-C4A93C037345Q48746787-2CB96D71-2228-4189-A0DB-E0E665D2CCC7Q48940568-E0033452-A038-4FCC-AAFF-5B14B2FF399EQ50043307-BBF209DA-7664-474B-8936-0AE846214584Q54700804-ACBBDE87-DBFD-49EF-B55D-9CA6F3DB3AC3Q55008538-3AB89C53-B6FB-4AE9-97FF-69C554C7E029Q56264476-C11B2648-F7FE-4F1A-8DC5-07DE5C781043Q80604345-5E386CFF-739A-43F5-B1E0-216DC1B93495
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Raffaele Iorio
@ast
Raffaele Iorio
@en
Raffaele Iorio
@es
Raffaele Iorio
@nl
Raffaele Iorio
@sl
type
label
Raffaele Iorio
@ast
Raffaele Iorio
@en
Raffaele Iorio
@es
Raffaele Iorio
@nl
Raffaele Iorio
@sl
prefLabel
Raffaele Iorio
@ast
Raffaele Iorio
@en
Raffaele Iorio
@es
Raffaele Iorio
@nl
Raffaele Iorio
@sl
P1053
E-1236-2014
P106
P1153
55482375800
P21
P31
P3829
P496
0000-0002-6270-0956
P569
2000-01-01T00:00:00Z